ImmunoViroTherapy Lab

The IVTLab is an international and interdisciplinary laboratory promoting cutting-edge research in the field of oncoimmunology and immunotherapy using viruses as platforms to induce and/or orchestrate the tumor-specific immune response. The laboratory is well supported and funded by prestigious and internationally recognised funding agencies such as the European Research Council Consolidator grant (ERC-CoG), HiLIFE, Jane and Aatos Erkko Foundation and Tekes.

Twitter and News

@vincersurf

SPOTLIGHT: Exploiting pre-existing immunity to enhance oncolytic cancer immunotherapy @helsinkiuni @vincersurf Orig… twitter.com/i/web/status/1…

I am very proud of this work! @ValoTherapeuti1 @helsinkiuni @iCAN_Finland @TRIMMprogram twitter.com/LifeSciHelsink…

Battle with the cancer: new avenues from childhood vaccines | very proud to share our just accepted paper! life is… twitter.com/i/web/status/1…

Press release: Valo Therapeutics Announces New Funding for Immuno-Oncology Trials! #immunotherapy #biotechnologytwitter.com/i/web/status/1…